Donate this Christmas, and help give Australians like Daniel greater agency and optimism next year.

Opt Me In is the new infrastructure that lets Australians with brain cancer easily take part in data-driven trials and research studies.
Opt Me In will open up new possibilities for advances in brain cancer research – but only if it is supported by funding.

Your donation here now could fund research like the VORA study, the first patient-powered study run through Opt Me In.

Help raise $150,000 this Christmas for this and other vital brain cancer research.

For too long, many Australians diagnosed with brain cancer experienced a sense of helplessness. Why was life expectancy so short? Why was there so little research being funded? And so few new treatments? Why was it so difficult for patients to find and take part in research studies and trials?

Opt Me In removes many barriers to patient participation in research. It will help give researchers vital, real-world data in a more cost-effective way than before.

Donate today, and help find more brain cancer breakthroughs, faster.

“The launch of Opt Me In is the result of years of work driven by one purpose: making things better for people with brain cancer.” – Robyn Leonard, Founder and Director, Brain Cancer Australia.

Daniel is among thousands of Australians with brain cancer who are waiting and hoping for new treatments. With your help today, the VORA study through Opt Me In will be part of a new and more productive era of brain cancer research.

Please, donate generously this Christmas.

Daniel Campbell resting in a hospital bed

Daniel can’t forget the awful meeting in a hospital room. Doctors told him that the mass on his brain was a grade two IDH-mutant glioma. Even after surgery, it would probably grow back in 5-7 years. There is no cure.

Daniel is a husband and father of two. He lives with a devastating diagnosis, and some negative effects from his cancer and cancer treatment.

He is now on a new drug called vorasidenib, which he hopes will give him more time. And, he is helping researchers study the effects and effectiveness of vorasidenib by taking part in the VORA study.

Daniel says it’s reassuring to know that there is new brain cancer research happening. Now, through Opt Me In, patients like Daniel have a way to power that research.

Will you please donate this Christmas to join them, and help change outcomes for Australians with brain cancer.

Your gift will help to fund a national approach to accelerating research and improving patient care.

Australian Brain Cancer Registry

To collect the clinical data needed to standardise and improve brain cancer patient care.

Opt Me In Platform

Opt Me In Platform

To facilitate cost-effective, data-driven clinical trials and enable patients to enrol themselves for research.

Biobanking and Organoid Platform

To standardise procedures, enable linkage of patient data to collected biospecimens, and accelerate innovative genomic brain cancer research.

80% of brain cancer patients will die within 5 years

Brain cancer kills more children than any other disease

2,000 Australians are diagnosed with brain cancer each year


Brain Cancer Australia Charity Ltd is a registered charity with DGR status.
ABN: 19 627 717 926. PO Box 170 Gordon NSW 2072.
Email info@braincanceraustralia.org.au